Skip to main content

IMMUNOLOGY2026™ Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Rachel Y. Ames, PhD

Associate Director
RAPT Therapeutics, Inc.

Poster(s):

(201) Ozureprubart, a next-gen anti-IgE antibody, inhibits IgE binding to FcεRI, dissociates FcεRI-bound IgE, and reduces FcεRI expression on basophils

Saturday, April 18, 2026
11:30 AM - 12:30 PM US ET